- PREVEXXION RN is the result of unprecedented engineering design in vaccines, balancing optimal performance and efficacy
- PREVEXXION RN benefits from an early, five days of age onset of immunity against Marek’s Disease, providing full protection against very virulent Marek’s Disease virus strains for broilers, layers and breeders
- PREVEXXION RN is also fully compatible with VAXXITEK HVT+IBD
Boehringer Ingelheim Animal Health is pleased to announce the launch of PREVEXXION RN, the next generation of Marek’s Disease vaccines.
PREVEXXION RN is the first innovation in the Marek’s disease category for over 40 years. Licensed for use in day old broilers, layers and breeders, its purpose is to provide poultry producers with premium Marek’s Disease protection using cutting-edge technology.
The new RN1250 PREVEXXION strain is the result of an unprecedented engineering vaccine design, taking the best traits from three different existing strains of MDV to create the first hybrid, next generation, vaccine against Marek’s Disease. PREVEXXION RN provides a unique balance between safeguarding bird health and efficacy against the most virulent types of Marek’s Disease virus strains.
PREVEXXION RN can be combined with VAXXITEK HVT+IBD resulting in a unique, high-performance vaccine providing protection against MD and infectious bursal disease (IBD/Gumboro). This solution is specifically designed to answer customer needs in long-life bird segments with the most appropriate protection from the hatchery. PREVEXXION RN vaccines are available in ampoules of 1000 and 2000 doses, stored frozen in liquid nitrogen.
Jerôme Baudon, Head of Poultry in Boehringer Ingelheim, said: “Our PREVEXXION RN range provides value through innovation to poultry producers looking for continuous live production productivity improvement and effective protection in the face of Marek’s Disease challenge. Field and lab experiments conducted worldwide demonstrated its efficacy and early, long-lasting and robust protection through the lifespan of the birds, and against very virulent Marek’s Disease challenge. PREVEXXION RN is the new gold standard for Marek’s disease vaccination programs”.
The future is now!
Poultry producers can contact their Boehringer Ingelheim Animal Health Avian Specialist to know more about PREVEXXION RN range.
